Escape of HIV-1 from a small molecule CCR5 inhibitor is not associated with a fitness loss.
Fitness is a parameter used to quantify how well an organism adapts to its environment; in the present study, fitness is a measure of how well strains of human immunodeficiency virus type 1 (HIV-1) replicate in tissue culture. When HIV-1 develops resistance in vitro or in vivo to antiretroviral drug...
Main Authors: | Cleo G Anastassopoulou, Andre J Marozsan, Alexandre Matet, Amy D Snyder, Eric J Arts, Shawn E Kuhmann, John P Moore |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2007-06-01
|
Series: | PLoS Pathogens |
Online Access: | http://europepmc.org/articles/PMC1885273?pdf=render |
Similar Items
-
HIV-1 Escape From Small Molecule CCR5 Inhibitors In Vitro
by: Kuhmann Shawn
Published: (2005-12-01) -
Two HIV-1 variants resistant to small molecule CCR5 inhibitors differ in how they use CCR5 for entry.
by: Reem Berro, et al.
Published: (2009-08-01) -
CCR5 Targeted Cell Therapy for HIV and Prevention of Viral Escape
by: Gero Hütter, et al.
Published: (2015-07-01) -
A systemically-administered small molecule antagonist of CCR9 acts as a tissue-selective inhibitor of lymphocyte trafficking.
by: Noah J Tubo, et al.
Published: (2012-01-01) -
Reversion and T cell escape mutations compensate the fitness loss of a CD8+ T cell escape mutant in their cognate transmitted/founder virus.
by: Song, H, et al.
Published: (2014)